| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Platform: GPL24247
|
Expression profiling by high throughput sequencing
|
TXT
|
Hongjian Jin
|
||||
| GSE253185 |
Credentialling a c-MYC-driven genetic neuroblastoma model
|
|
5 |
|
Hongjian Jin | Nov 05, 2024 | ||
| GSE193124 |
Genome-wide mapping of oncogenic pathways and genetic modifiers of chemotherapy using a high-risk hepatoblastoma genetic model
|
|
6 |
|
Hongjian Jin | Jun 22, 2023 | ||
| GSE166808 |
Quantitative assessment of transcriptomic differences between ASPcKO and ASPcKOP7cKO flow cytometry-sorted murine FN-RMSs by RNA sequencing
|
|
8 |
|
Hongjian Jin | Aug 24, 2021 | ||
| GSE166906 |
Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity
|
|
29 |
|
Hongjian Jin | Aug 24, 2021 | ||
| GSE218357 |
PAX3-FOXO1 drives tumor formation from multiple lineages [RNA-seq]
|
|
31 |
|
Hongjian Jin | Sep 30, 2023 | ||
| GSE172221 |
A genetic mouse model of malignant peripheral nerve sheath tumor with postnatal Nf1 and p53 loss recapitulates the histology and transcriptome of human tumors
|
|
44 |
|
Hongjian Jin | Mar 24, 2024 | ||
| GSE218274 |
PAX3-FOXO1 expression in endothelial progenitors dictates myogenic reprogramming and rhabdomyosarcoma identity
|
|
75 | Hongjian Jin | Sep 29, 2023 |
